Aligos Therapeutics Inc.

23.69
-0.25 (-1.06%)
At close: Jan 30, 2025, 3:59 PM
23.80
0.44%
After-hours Jan 30, 2025, 05:12 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 135.70M 81.35M 186.82M 220.38M 69.56M 24.04M
Short-Term Investments n/a 44.48M 3.92M 23.13M 48.10M 66.82M
Long-Term Investments n/a n/a 15.11M n/a 10.02M n/a
Other Long-Term Assets 625.00K -2.53M 866.00K -3.29M 188.00K 178.00K
Receivables n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a
Other Current Assets 5.38M 7.72M 13.69M 6.50M 2.56M 1.52M
Total Current Assets 141.08M 133.54M 204.42M 250.02M 120.23M 92.37M
Property-Plant & Equipment 9.82M 12.51M 14.97M 14.91M 16.09M 15.18M
Goodwill & Intangibles n/a n/a -3.77M n/a n/a n/a
Total Long-Term Assets 10.44M 13.15M 30.95M 15.29M 26.29M 15.36M
Total Assets 151.53M 146.69M 235.37M 265.30M 146.52M 107.73M
Account Payables 2.52M 4.74M 3.02M 3.31M 3.77M 2.98M
Deferred Revenue 1.31M 9.21M 7.64M 7.89M 6.85M 3.18M
Short-Term Debt 10.38M 6.29M 5.81M 5.01M 2.45M 1.25M
Other Current Liabilities 16.84M 12.90M 22.49M 14.06M 7.60M 3.26M
Total Current Liabilities 23.91M 33.13M 38.96M 30.27M 13.82M 7.49M
Long-Term Debt 7.90M 9.43M 11.55M 10.50M 11.88M 12.61M
Other Long-Term Liabilities 27.64M n/a 133.00K 379.00K 185.71M 101.38M
Total Long-Term Liabilities 35.54M 9.66M 11.68M 14.99M 197.59M 113.99M
Total Liabilities 59.45M 42.79M 50.64M 45.26M 211.41M 121.48M
Total Debt 11.14M 12.57M 14.46M 13.01M 14.33M 13.86M
Common Stock 7.00K 4.00K 4.00K 4.00K 4.00K 3.00K
Retained Earnings -486.80M -399.12M -303.07M -174.74M -66.20M -13.93M
Comprehensive Income 545.00K 401.00K 452.00K -188.00K -115.00K 3.00K
Shareholders Equity 92.08M 103.90M 184.73M 220.04M -64.89M -13.75M
Total Investments -70.00K 44.48M 19.03M 23.13M 58.12M 66.82M